Rare diseases
Investigational molecules
Locations
Ul. Zwirki I Wigury 61, 02-091 Warsaw, Poland
Research activity includes treatment strategies for relapsed or resistant B-cell acute lymphoblastic leukemia with measurable residual disease and light chain amyloidosis, with interest in immune-based and supportive approaches for marrow and organ involvement.
The sponsor also supports studies in myelosuppression and hematologic recovery linked to complex cancer care.
Medical University Of Warsaw runs clinical trials in conditions such as Peripheral arterial occlusive disease, Diabetic foot, IgA nephropathy, Neurofibromatosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PolandPolandPolandPolandPolandPolandPolandPolandPolandPolandPolandPolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
